NeuroMetrix, Inc. Reports Total Revenues Of $14.2 Million For The Fourth Quarter Of 2006, Representing 37% Growth Over The Fourth Quarter Of 2005; GAAP Net Income Of $1.2 Million, Non-GAAP Adjusted Net Income Of $1.9 Million

WALTHAM, Mass.--(BUSINESS WIRE)--NeuroMetrix, Inc. (Nasdaq: NURO), a medical device company focused on the design, development and sale of proprietary products used to help physicians diagnose neuropathies, or diseases of the nerves, and neurovascular diseases, announced today the financial results for the three and twelve month periods ended December 31, 2006.